ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GE9 Genmab AS

260.80
2.40 (0.93%)
01 Jun 2024 - Closed
Realtime Data
Share Name Share Symbol Market Stock Type
Genmab AS GE9 Tradegate Ordinary Share
  Price Change Price Change % Share Price Last Trade
2.40 0.93% 260.80 07:50:06
Open Price Low Price High Price Close Price Previous Close
258.90 258.20 261.00 260.80 258.40
more quote information »

Recent News

Date Time Source Heading
03/6/202407:30GLOBEPreliminary Analysis of Data Evaluating Investigational..
02/6/202400:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in..
28/5/202400:16GLOBETransactions in Connection with Share Buy-back Program
24/5/202407:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
22/5/202401:06GLOBEGenmab Completes Acquisition of ProfoundBio
21/5/202421:19GLOBETransactions in Connection with Share Buy-back Program
15/5/202400:02GLOBEGenmab to Present New and Updated Results From Multiple..
14/5/202400:09GLOBETransactions in Connection with Share Buy-back Program
08/5/202404:27GLOBECapital Increase in Genmab as a Result of Employee Warrant..
07/5/202400:01GLOBETransactions in Connection with Share Buy-back Program
03/5/202401:01GLOBEGenmab Announces Financial Results for the First Quarter of..
30/4/202408:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
29/4/202418:24GLOBETransactions in Connection with Share Buy-back Program..
22/4/202417:30GLOBETransactions in Connection with Share Buy-back Program..
16/4/202420:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
15/4/202418:07GLOBETransactions in Connection with Share Buy-back Program..
08/4/202419:44GLOBETransactions in Connection with Share Buy-back Program
03/4/202416:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
02/4/202418:24GLOBETransactions in Connection with Share Buy-back Program
26/3/202400:30GLOBETransactions in Connection with Share Buy-back Program
18/3/202420:49GLOBECompletion of share buy-back program
15/3/202423:16GLOBEGenmab Announces Initiation of Share Buy-Back Program
14/3/202407:58GLOBETransactions with shares and linked securities in Genmab A/S..
14/3/202407:52GLOBEConstitution of the Board of Directors in Genmab A/S, Grant..
14/3/202402:13GLOBEPassing of Genmab A/S’ Annual General Meeting
11/3/202420:42GLOBETransactions in connection with share buy-back program
05/3/202405:10GLOBETransactions with shares and linked securities in Genmab A/S..
04/3/202420:29GLOBETransactions in connection with share buy-back program
02/3/202410:04GLOBETransactions with shares and linked securities in Genmab A/S..
01/3/202402:48GLOBETransactions with shares and linked securities in Genmab A/S..
28/2/202407:42GLOBETransactions with shares and linked securities in Genmab A/S..
28/2/202407:40GLOBECapital Increase in Genmab as a Result of Employee Warrant..
27/2/202411:45GLOBEU.S. FDA Accepts for Priority Review the Supplemental..
26/2/202421:21GLOBETransactions in connection with share buy-back program
24/2/202409:50GLOBETransactions with shares and linked securities in Genmab A/S..
24/2/202409:35GLOBEGrant of Restricted Stock Units to Management and Employees..
19/2/202420:40GLOBETransactions in connection with share buy-back program
15/2/202422:00GLOBENotice to Convene the Annual General Meeting of Genmab A/S
15/2/202406:09GLOBEGenmab Files Annual Report with the U.S. Securities and..
15/2/202403:41GLOBEGenmab Announces Initiation of Share Buy-Back Program
15/2/202403:02GLOBEGenmab Publishes 2023 Annual Report
02/2/202422:45GLOBETisotumab Vedotin Marketing Authorization Application..
26/1/202406:22GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
23/1/202422:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
23/1/202410:40GLOBEGenmab Announces Decision in Arbitration Appeal under..
09/1/202422:45GLOBETIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
03/1/202416:55GLOBETransactions With Shares and Linked Securities in Genmab A/S..
03/1/202401:52GLOBEGenmab to Present at the 42nd Annual J.P. Morgan Healthcare..
12/12/202323:00GLOBEGenmab to Hold 2023 R&D Update and ASH Data Review Meeting
10/12/202304:00GLOBENew Pivotal Data for Bispecific Antibody Epcoritamab..

Your Recent History

Delayed Upgrade Clock